Silvia Di Giacomo Selected Research

Silvia Di Giacomo Research Topics

Disease

12	Neoplasms (Cancer) 05/2024 - 12/2018
5	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 01/2018
4	Cholangiocarcinoma 06/2022 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 09/2022
2	Infections 05/2023 - 08/2018
2	Breast Neoplasms (Breast Cancer) 09/2022 - 11/2021
2	Triple Negative Breast Neoplasms 09/2022 - 11/2021
2	Hyperglycemia 09/2022 - 08/2019
2	Liver Neoplasms (Liver Cancer) 01/2019 - 01/2018
1	Virus Diseases (Viral Diseases) 09/2023
1	Inflammation (Inflammations) 09/2023
1	Lung Diseases (Lung Disease) 05/2023
1	COVID-19 05/2023
1	Genomic Instability 09/2022
1	Neuroinflammatory Diseases 09/2022
1	Insulin Resistance 09/2022
1	Obesity 08/2022
1	Ketosis 08/2022
1	Erythema 07/2022
1	Acne Vulgaris 07/2022
1	Adenocarcinoma 06/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022
1	Confusion (Bewilderment) 01/2022
1	Wounds and Injuries (Trauma) 08/2020
1	Immune System Diseases (Immune Disorders) 08/2020
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2020
1	Hypoxia (Hypoxemia) 08/2018
1	Human Influenza (Influenza) 01/2018
1	Hepatoblastoma 01/2018
1	Dementia (Dementias) 09/2016
1	Cognitive Dysfunction 09/2016
1	Urinary Incontinence 03/2016
1	Necrosis 11/2013

Drug/Important Bio-Agent (IBA)

6	SesquiterpenesIBA 09/2022 - 01/2020
4	caryophylleneIBA 09/2022 - 01/2020
3	AntioxidantsIBA 07/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2019
3	Polycyclic SesquiterpenesIBA 06/2022 - 10/2020
3	caryophyllene oxideIBA 11/2021 - 01/2019
2	SeleniumIBA 01/2024 - 12/2022
2	Antiviral Agents (Antivirals)IBA 09/2023 - 08/2018
2	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 08/2022
2	Sorafenib (BAY 43-9006)FDA Link 06/2022 - 01/2019
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2019
2	multidrug resistance-associated protein 1IBA 01/2022 - 01/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2020
1	Immune Checkpoint InhibitorsIBA 05/2024
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2024
1	Serotonin ReceptorsIBA 01/2024
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2023
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 11/2023
1	tylophorineIBA 09/2023
1	AlkaloidsIBA 09/2023
1	lycorineIBA 09/2023
1	Leukotriene D4IBA 05/2023
1	Selenomethionine (Sethotope)FDA Link 12/2022
1	SelenocysteineIBA 12/2022
1	SmokeIBA 09/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 09/2022
1	ferulic acid (sodium ferulate)IBA 09/2022
1	Biomarkers (Surrogate Marker)IBA 08/2022
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2022
1	CannabidiolIBA 11/2021
1	humuleneIBA 11/2021
1	CB2 Cannabinoid ReceptorIBA 11/2021
1	cannabichromeneIBA 11/2021
1	Immunologic Factors (Immunomodulators)IBA 08/2020
1	Prostaglandins EIBA 08/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Phosphatidylcholines (Phosphatidylcholine)IBA 12/2018
1	Liposomes (Liposome)IBA 12/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 08/2018
1	ResveratrolIBA 09/2016
1	CurcuminIBA 09/2016
1	oxybutynin (Tavor)FDA LinkGeneric 03/2016
1	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2013
1	BilirubinIBA 11/2013

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 05/2024 - 01/2018
2	Chemoprevention 10/2020 - 01/2020
1	Therapeutics 12/2022